Literature DB >> 901673

Beta blockade in essential hypertension: an analysis of response to oxprenolol.

D W Barritt, A J Marshall.   

Abstract

The data from 40 patients with essential hypertension treated with oxprenolol alone have been used to analyse the falls of blood pressure and heart rate. Blood pressure and heart rate did not fall further as the daily dose was increased above 160 mg. The range of fall in mean pressure was from 0 to 40 mmHg and there was no clear separation into response groups. Pressure falls were unrelated to sex, age, initial heart rate, increase in heart rate on standing, the fall of heart rate with the drug, or the initial height of blood pressure. In the absence of predicting factors the use of oxprenolol, and, by deduction, other beta blocking agents, in hypertension remains empirical, but the simplification of the dose range allows the response to oxprenolol to be determined quickly.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 901673      PMCID: PMC483325          DOI: 10.1136/hrt.39.8.825

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  5 in total

1.  Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.

Authors:  C Davidson; U Thadani; W Singleton; S H Taylor
Journal:  Br Med J       Date:  1976-07-03

2.  Oxprenolol in hypertension.

Authors:  A J Marshall; D W Barritt
Journal:  Br J Clin Pract       Date:  1973-09

3.  Propranolol in hypertension: a dose-response study.

Authors:  D B Galloway; S C Glover; W G Hendry; A W Logie; J C Petrie; M C Smith; J A Lewis; W T Simpson
Journal:  Br Med J       Date:  1976-07-17

4.  Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.

Authors:  D W Barritt; A J Marshall; S Heaton
Journal:  Lancet       Date:  1976-03-06       Impact factor: 79.321

5.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04
  5 in total
  6 in total

Review 1.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 2.  Treating hypertension. The place of beta blockade.

Authors:  D W Barritt; A J Marshall
Journal:  Br Heart J       Date:  1977-08

3.  Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.

Authors:  G T McInnes; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Dangerous antihypertensive treatment.

Authors:  D W Barritt; A J Marshall
Journal:  Br Med J       Date:  1979-09-08

5.  Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.

Authors:  A J Marshall; M A Kettle; D W Barritt
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

6.  Effects of indomethacin on postural hypotension in Parkinsonism.

Authors:  G Abate; R M Polimeni; F Cuccurullo; P Puddu; S Lenzi
Journal:  Br Med J       Date:  1979-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.